ASTRAZENECA PHARMA INDIA LTD.
Smart Quotes
Trade Value (Rs. in Lacs) | 0.00 |
Dividend Yield(%) | 0.31 |
TTM EPS (Rs.) | 55.72 |
P/E Ratio | 93.41 |
Book Value (Rs.) | 268.31 |
Face Value (Rs.) | 2 |
MCap (Rs. in Mn) | 130117.50 |
Price/Earning (TTM) | 84.10 |
Price/Sales (TTM) | 10.87 |
Price/Book (MRQ) | 19.40 |
PAT Margin (%) | 9.85 |
ROCE (%) | 24.49 |
Management Info :
Narayan K Seshadri - Chairman Sanjeev Kumar Panchal - Managing DirectorRegistered Office :
Address :
Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring Road,
Bengaluru,
Karnataka-560045
Phone : 080 6774 8000
Email : comp.secy@astrazeneca.com
Website : www.astrazenecaindia.com/india
QTR Dec 23 | ANNUAL 23 | |
---|---|---|
Net Profit | 158 | 992.929999999999 |
Gross Profit | 203.98 | 1341.05 |
Operating Profit | 247.16 | 1914.27 |
Net Sales | 3057.89 | 10029.71 |
NGL Fine-Chem (BSE)  2542.60 (12.29%) | M.Cap ( in Cr) 1570.82 |
Neuland Laboratories (BSE)  7654.80 (1.79%) | M.Cap ( in Cr) 9821.02 |
Mankind Pharma (BSE)  2397.40 (5.05%) | M.Cap ( in Cr) 96037.07 |
Sanofi India (BSE)  8470.70 (0.89%) | M.Cap ( in Cr) 19508.55 |
Solara Active Pharma (BSE)  474.10 (12.15%) | M.Cap ( in Cr) 1706.58 |
|
PROMOTERS | 75 % |
|
MUTUAL FUNDS/UTI | 3.75 % |
|
NON-INSTITUTION | 18.49 % |
|
FI/BANKS/INSURANCE | 0 % |
|
GOVERNMENT | 0 % |
|
FII | 0 % |
Scheme Name | Hold(%) |
---|---|
Quant Healthcare Fund-R... | 2.34 |
ICICI Pru Pharma Health... | 1.61 |
ICICI Pru Innovation Fu... | 0.93 |
Nippon India Small Cap ... | 0.76 |
Nippon India Pharma Fun... | 0.48 |
Motilal Oswal S&P BSE H... | 0.33 |